MODULATION OF APOLIPOPROTEIN B GENE EXPRESSION
载脂蛋白 B 基因表达的调节
基本信息
- 批准号:3858027
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:apolipoproteins blood lipoprotein biosynthesis chylomicrons developmental genetics dietary lipid gene expression hormone regulation /control mechanism human tissue laboratory rat lipid transport liver metabolism low density lipoprotein posttranscriptional RNA processing posttranslational modifications small intestines thyroid hormones very low density lipoprotein
项目摘要
Apolipoprotein B is the principal apolipoprotein on chylomicrons, ow
density lipoproteins, intermediate lipoproteins, and low density
lipoproteins. Apolipoprotein B exists in human plasma in two forms, the
full length apoB-100 and the shorter apoB-48. ApoB-100 is synthesized
primarily by the liver, whereas apoB-48 is derived exclusively from the
small intestine. Both forms of the protein are requisite for the normal
transport and delivery of dietary and endogenous lipids to target
tissues. Both proteins are the product of a single gene which encodes a
mRNA that may either be directly translated into the full-length apoB-100
or, alternatively, be modified by conversion of single nucleotide that
results in the replacement of the codon CAA at position 2153 with the
premature STOP codon UAA. This modification results in the shorter
translation product apoB-48 and is referred to as mRNA "editing." By
analysis of mRNA derived from human and rat tissues at various stages of
development, our laboratory this year has demonstrated that the capacity
to edit apoB mRNA is developmentally controlled in a -tissue and
species-specific manner. Furthermore, we have demonstrated that one of
the requisite developmental tissue-specific signals is thyroid hormone:
in the absence of thyroid hormone normal editing does not develop in the
liver, while the small intestine edits normally; administration of
thyroid hormone can restore normal editing in the developing liver.
载脂蛋白B是乳糜微粒上的主要载脂蛋白,
密度脂蛋白、中等密度脂蛋白和低密度脂蛋白
脂蛋白 载脂蛋白B以两种形式存在于人血浆中,
全长apoB-100和较短的apoB-48。 合成ApoB-100
主要是由肝脏,而apoB-48是完全来自
小肠 这两种形式的蛋白质是必需的正常
将膳食和内源性脂质运输和递送至目标
组织中 这两种蛋白质都是同一个基因的产物,
mRNA可以直接翻译成全长apoB-100
或者可选择地,通过转化单核苷酸进行修饰,
导致2153位的密码子CAA被替换为
提前终止密码子UAA。 这种修改导致较短的
翻译产物apoB-48,被称为mRNA“编辑”。“由
分析来自人和大鼠组织在不同阶段的mRNA,
我们的实验室今年已经证明,
编辑apoB mRNA在组织中受到发育控制,
物种特有的方式。此外,我们已经证明,
必要的发育组织特异性信号是甲状腺激素:
在没有甲状腺激素的情况下,
肝脏,而小肠正常编辑;施用
甲状腺激素可以恢复发育中肝脏的正常编辑。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A P PATTERSON其他文献
A P PATTERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A P PATTERSON', 18)}}的其他基金
MRNA EDITING PROTEINS--POSTTRANSCRIPTIONAL REGULATION OF HUMAN GENE EXPRESSION
mRNA编辑蛋白--人类基因表达的转录后调控
- 批准号:
2568990 - 财政年份:
- 资助金额:
-- - 项目类别:
MRNA EDITING PROTEINS--POSTTRANSCRIPTIONAL REGULATION OF HUMAN GENE EXPRESSION
mRNA编辑蛋白--人类基因表达的转录后调控
- 批准号:
6101252 - 财政年份:
- 资助金额:
-- - 项目类别:
MRNA EDITING PROTEINS--POSTTRANSCRIPTIONAL REGULATION OF HUMAN GENE EXPRESSION
mRNA编辑蛋白--人类基因表达的转录后调控
- 批准号:
6161312 - 财政年份:
- 资助金额:
-- - 项目类别:
DEVELOPMENTAL AND HORMONAL REGULATION OF APOLIPOPROTEIN B GENE EXPRESSION
载脂蛋白 B 基因表达的发育和激素调节
- 批准号:
5200777 - 财政年份:
- 资助金额:
-- - 项目类别:
DEVELOPMENTAL AND HORMONAL REGULATION OF APOLIPOPROTEIN B GENE EXPRESSION
载脂蛋白 B 基因表达的发育和激素调节
- 批准号:
3748219 - 财政年份:
- 资助金额:
-- - 项目类别: